APPLICATION
ANDA078058
TYPE
ANDA
ORIGINAL APPROVAL
2010-06-28
LATEST ACTION
2024-05-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
ANASTROZOLEPrescription
ANASTROZOLE 1MG · TABLET · ORAL
Approval history
2024-05-17Labeling · Supplement 14 · standardAP
2020-10-28Labeling · Supplement 11 · standardAP
2015-07-23Labeling · Supplement 7 · standardAP
2015-07-23Labeling · Supplement 8 · standardAP
2013-04-08Labeling · Supplement 5 · standardAP
2011-11-22Labeling · Supplement 4AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.